+467.0%
MRNA vs LCID
-78.4%
+545.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LCID | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.0% | +4.4% | +5.0% |
| 7D | -1.1% | -9.8% | +8.7% | +2.6% |
| 30D | +126.1% | -35.5% | +161.6% | +162.8% |
| 3M | +190.0% | -18.4% | +208.4% | +198.8% |
| 6M | +157.2% | -60.5% | +217.7% | +246.2% |
| YTD | +388.2% | -60.1% | +448.3% | +542.2% |
| 1Y | +467.0% | -78.8% | +545.8% | +846.2% |
| All | +467.0% | -78.4% | +545.4% | +846.2% |
Cumulative growth
Daily Returns
Daily percentage return beside LCID.
Daily Out/Under-Performance
Portfolio return minus LCID return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LCID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LCID wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling